Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CARLOS SINGER

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1285654335
CMS profile
149477
Location
MIAMI, FL

General Payments · PY2018–2024

$10,921.84

  • Reported across 41 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$449.86

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $293.93 15
Travel and Lodging $155.93 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $300.25 4
ABBVIE INC. $149.61 12

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,620.28 14
PY2019 $3,590.56 3
PY2020 $134.39 2
PY2022 $37.06 2
PY2023 $89.69 4
PY2024 $449.86 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $4.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106108308 CMS
ABBVIE INC. $25.58 03/08/2024 Food and Beverage Undisputed 01/23/2026 1106108310 CMS
ABBVIE INC. $9.72 03/25/2024 Food and Beverage Undisputed 01/23/2026 1106108312 CMS
ABBVIE INC. $22.67 04/04/2024 Food and Beverage Undisputed 01/23/2026 1106108314 CMS
ABBVIE INC. $3.52 04/15/2024 Food and Beverage Undisputed 01/23/2026 1106108316 CMS
ABBVIE INC. $5.21 05/22/2024 Food and Beverage Undisputed 01/23/2026 1106108318 CMS
ABBVIE INC. $23.81 05/28/2024 Food and Beverage Undisputed 01/23/2026 1106108320 CMS
ABBVIE INC. $8.16 06/13/2024 Food and Beverage Undisputed 01/23/2026 1106108322 CMS
ABBVIE INC. $23.98 07/16/2024 Food and Beverage Undisputed 01/23/2026 1106108324 CMS
ABBVIE INC. $7.73 08/15/2024 Food and Beverage Undisputed 01/23/2026 1106108326 CMS
ABBVIE INC. $5.25 09/25/2024 Food and Beverage Undisputed 01/23/2026 1106108328 CMS
ABBVIE INC. $9.98 11/11/2024 Food and Beverage Undisputed 01/23/2026 1106108330 CMS
Neurocrine Biosciences, Inc. $68.00 06/15/2024 Food and Beverage Undisputed 01/23/2026 1150813344 CMS
Neurocrine Biosciences, Inc. $50.27 06/15/2024 Food and Beverage Undisputed 01/23/2026 1150813990 CMS
Neurocrine Biosciences, Inc. $26.05 06/15/2024 Food and Beverage Undisputed 01/23/2026 1150836858 CMS
Neurocrine Biosciences, Inc. $155.93 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1150848726 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.